BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17706926)

  • 1. Antibacterial prophylaxis in neutropenic patients.
    Viscoli C
    Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S60-5. PubMed ID: 17706926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Almyroudis NG; Segal BH
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395832
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider.
    Lo N; Cullen M
    Hematol Oncol; 2006 Sep; 24(3):120-5. PubMed ID: 16783844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
    Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Freifeld AG; Sepkowitz KA; Martino P; Steven N; Billingham L; Cullen M; Baden LR
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16394310
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Ito JI; Tegtmeier BR; O'Donnell MR
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395829
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Pasqualotto AC; Rosa DD; Machado AL
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395830
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Eller P; Pechlaner C
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395828
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluoroquinolone prophylaxis in patients with neutropenia.
    Zinner SH
    Clin Infect Dis; 2005 Apr; 40(8):1094-5. PubMed ID: 15791506
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Castagna L; Santoro A
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395831
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fluoroquinolones to prevent bacterial infection in children with chemotherapy induced neutropenia: is it reasonable?].
    Dubos F; Delebarre M; Lagrée M
    Arch Pediatr; 2013 Nov; 20 Suppl 3():S90-3. PubMed ID: 24360309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropenia.
    Wingard JR; Eldjerou L; Leather H
    Curr Opin Hematol; 2012 Jan; 19(1):21-6. PubMed ID: 22080847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
    Candoni A; Russo D; Salmaso F
    Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylaxis using quinolones in neutropenic patients. Preliminary results of a cooperative study by the Grupo Italiano Malattie Ematologiche maligne dell'adulto (GIMEMEA)].
    Del Favero A; Martino P; Bucaneve G; Micozzi A; D'Antonio D; Minetti B; Ricci P; Landonio G; Montillo M; Malleo C
    Haematologica; 1989 Oct; 74(5 Suppl):278-86. PubMed ID: 2512214
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial prophylaxis for infection in neutropenic patients.
    Bodey GP
    Curr Clin Top Infect Dis; 1988; 9():1-43. PubMed ID: 3077285
    [No Abstract]   [Full Text] [Related]  

  • 16. The evolution of antibiotic therapy for neutropenic patients.
    Bodey GP
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2660-5. PubMed ID: 10068270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic approach to a patient with febrile neutropenia].
    Duraković N; Nemet D
    Lijec Vjesn; 2007; 129(10-11):344-50. PubMed ID: 18257335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic antimicrobial agents and the importance of fitness.
    Baden LR
    N Engl J Med; 2005 Sep; 353(10):1052-4. PubMed ID: 16148291
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis.
    Gafter-Gvili A; Paul M; Fraser A; Leibovici L
    J Antimicrob Chemother; 2007 Jan; 59(1):5-22. PubMed ID: 17077101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.